METHODS OF INHIBITING PATHOLOGICAL ANGIOGENESIS WITH DOPPEL-TARGETING MOLECULES

Described herein are doppel-targeting molecules useful for inhibiting pathological angiogenesis and treating diseases and conditions associated with pathological angiogenesis, such as tumors, cancers, atherosclerosis, tuberculosis, asthma, pulmonary arterial hypertension (PAH), neoplasms and neoplas...

Full description

Saved in:
Bibliographic Details
Main Authors JANG, Ye Ji, BYUN, Young Ro, TASLIM, Ahmed Al-Hilal, KIM, In San, KIM, Sang Yoon
Format Patent
LanguageEnglish
French
Published 22.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Described herein are doppel-targeting molecules useful for inhibiting pathological angiogenesis and treating diseases and conditions associated with pathological angiogenesis, such as tumors, cancers, atherosclerosis, tuberculosis, asthma, pulmonary arterial hypertension (PAH), neoplasms and neoplasm-related conditions, and for detecting doppel expression in a subject. Related compositions and methods also are described. L'invention concerne des molécules ciblant la protéine Doppel utiles pour inhiber une angiogenèse pathologique et traiter des maladies et des affections associées à une angiogenèse pathologique, telles que les tumeurs, les cancers, l'athérosclérose, la tuberculose, l'asthme, l'hypertension artérielle pulmonaire (HTAP), les néoplasmes et les troubles associés aux néoplasmes, tumeurs et pour détecter l'expression de la protéine Doppel chez un sujet. L'invention concerne également des compositions et des procédés associés.
AbstractList Described herein are doppel-targeting molecules useful for inhibiting pathological angiogenesis and treating diseases and conditions associated with pathological angiogenesis, such as tumors, cancers, atherosclerosis, tuberculosis, asthma, pulmonary arterial hypertension (PAH), neoplasms and neoplasm-related conditions, and for detecting doppel expression in a subject. Related compositions and methods also are described. L'invention concerne des molécules ciblant la protéine Doppel utiles pour inhiber une angiogenèse pathologique et traiter des maladies et des affections associées à une angiogenèse pathologique, telles que les tumeurs, les cancers, l'athérosclérose, la tuberculose, l'asthme, l'hypertension artérielle pulmonaire (HTAP), les néoplasmes et les troubles associés aux néoplasmes, tumeurs et pour détecter l'expression de la protéine Doppel chez un sujet. L'invention concerne également des compositions et des procédés associés.
Author TASLIM, Ahmed Al-Hilal
KIM, In San
KIM, Sang Yoon
BYUN, Young Ro
JANG, Ye Ji
Author_xml – fullname: JANG, Ye Ji
– fullname: BYUN, Young Ro
– fullname: TASLIM, Ahmed Al-Hilal
– fullname: KIM, In San
– fullname: KIM, Sang Yoon
BookMark eNqNyr0KwjAUQOEMOvj3DgHnQmtR6RjT2-RCmhtMpGMpEidJC_X9UcQHcDpw-NZskcYUV4xaCJpqz6nhaDVeMKBV3InPNaRQCsOFVUgKLHj0vMOgeU3OgcmCuCr4-pYMyJsBv2XLx_Cc4-7XDds3EKTO4jT2cZ6Ge0zx1Xd0yItzXh2L8iSq8j_1Bll8MdQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PROCÉDÉS D'INHIBITION D'UNE ANGIOGENÈSE PATHOLOGIQUE AVEC DES MOLÉCULES DE CIBLAGE DE LA PROTÉINE DOPPEL
ExternalDocumentID WO2017095136A9
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2017095136A93
IEDL.DBID EVB
IngestDate Fri Jul 19 13:03:03 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2017095136A93
Notes Application Number: WO2016KR13956
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180222&DB=EPODOC&CC=WO&NR=2017095136A9
ParticipantIDs epo_espacenet_WO2017095136A9
PublicationCentury 2000
PublicationDate 20180222
PublicationDateYYYYMMDD 2018-02-22
PublicationDate_xml – month: 02
  year: 2018
  text: 20180222
  day: 22
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
PHAROSGEN
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
RelatedCompanies_xml – name: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
– name: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
– name: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
– name: PHAROSGEN
Score 3.130719
Snippet Described herein are doppel-targeting molecules useful for inhibiting pathological angiogenesis and treating diseases and conditions associated with...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
SUGARS
VINEGAR
WINE
Title METHODS OF INHIBITING PATHOLOGICAL ANGIOGENESIS WITH DOPPEL-TARGETING MOLECULES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180222&DB=EPODOC&locale=&CC=WO&NR=2017095136A9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJo1DdFjR9ommj2tjjY2McDMWPrWA1bF1aEN0PLHkzMIDLj37ddQHnirblrLu2l17tr7wPgqcON-VyeC11Vq5MOimfrnBtCtwqDd2zuOdxVCc5JascT63XWmzXgc5sLU9cJ_amLI0qJElLeq_q-Xv0_YoV1bOX6mX9I0PIlYv1Q23jHqpxZt6uFgz7OaEgDLQik36alY4VzlDVh2r53AIfSkHaUPOC3gcpLWe0qlegMjjJJr6zOoVGULTgJtr3XWnCcbL685XAjfesLoAlmMQ1zRCNE0pgMCCPpEGU-i7c9DZCfDglV8Wg5ydGUsBiFNMvwSGf-eIjr-Qkd4WAywvklPEaYBbEuV_b-x4j3Kd3dhnkFzXJZFteAuAQId273hCntn4XputwSpvAKQziuJRY30N5H6XY_-g5OFWvrRO5uG5rV13dxL1VxxR9qDv4CPQmFnA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJoxDdFjR-oSzR7Wxxs7OOBmLF1rLqtCyvCG6FlDyYGiMz4920XUJ54a-6aS3vp9e7a-wB4ajN9NhPnQpPV6oSD4loaYzrXzEJnbYu5NnNkgnOSWtHIfJ10JzX43ObCVHVCf6riiEKiuJD3srqvV_-PWEEVW7l-Zh8CtHwJaS9QN96xLGfW6ahBv4cyEhBf9X3ht6npUOJsaU0YlucewKEwsm0pD-i9L_NSVrtKJTyFo0zQW5RnUCsWTWj4295rTThONl_eYriRvvU5kATRiAS5QkIFpxHuY4rTgZJ5NNr2NFC8dICJjEfLca6MMY2UgGQZijXqDQeomp-QGPmjGOUX8Bgi6keaWNn0jxHTMdndhnEJ9cVyUVyBwgSAOzOryw1h_8wNx2EmN7hb6Nx2TD6_htY-Sjf70Q_QiGgST2Ocvt3CiWRzldTdaUG9_Pou7oRaLtl9xc1frYeIjw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHODS+OF+INHIBITING+PATHOLOGICAL+ANGIOGENESIS+WITH+DOPPEL-TARGETING+MOLECULES&rft.inventor=JANG%2C+Ye+Ji&rft.inventor=BYUN%2C+Young+Ro&rft.inventor=TASLIM%2C+Ahmed+Al-Hilal&rft.inventor=KIM%2C+In+San&rft.inventor=KIM%2C+Sang+Yoon&rft.date=2018-02-22&rft.externalDBID=A9&rft.externalDocID=WO2017095136A9